Compare
Merck & vs Organon & (MRK vs OGN)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Merck & (MRK) returned +73.9% and Organon & (OGN) +117.4%; so far this year the figures are +39.4% and +93.4%.
Merck & is the larger company by market value, about 99.4 times the size of Organon &.
On trailing earnings, MRK trades at 149.7 times and OGN at 18.0 times.
Revenue grew +4.9% at MRK and -3.2% at OGN over the last year.
MRK yields 2.32%. OGN yields 0.58%.
Data as of the latest close. Not investment advice.
Relative performance
| MRK | OGN | |
|---|---|---|
| Price | $146.73 | $13.87 |
| 1-day | -0.14% | +0.58% |
| YTD | +39.40% | +93.44% |
| 1 year | +73.87% | +117.40% |
| 3 years | +42.66% | -5.32% |
| Market cap | $361.7B | $3.6B |
| P/E | 149.7 | 18.0 |
| P/S | 5.37 | 0.60 |
| P/B | 8.06 | 3.05 |
| Revenue growth | +4.90% | -3.20% |
| EPS growth | -87.10% | -59.70% |
| Gross margin % | 71.8 | 53.1 |
| Net margin % | 3.6 | 3.5 |
| ROE % | 5.5 | 17.9 |
| Debt / equity | 1.20 | 7.17 |
| FCF yield % | 4.1 | 18.5 |
| Dividend yield % | 2.32 | 0.58 |
| Beta | 0.18 | 0.68 |
| RSI (14) | 51.3 | 64.0 |
| Technical rating |